63 Biggest Movers From Yesterday
Gainers
Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share.
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase 2b/3 Study
Marinus Pharmaceuticals Completes In Vivo M2 Metabolite Study And Provides European Regulatory Update
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced preliminary results from an in
SVB Leerink Maintains Outperform on Marinus Pharmaceuticals, Lowers Price Target to $30
SVB Leerink analyst Marc Goodman maintains Marinus Pharmaceuticals (NASDAQ:MRNS) with a Outperform and lowers the price target from $32 to $30.
Marinus Pharmaceuticals Announces New Clinical And Research Data To Be Presented At American Epilepsy Society Meeting On Dec. 6 At 1 p.m. EST
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced new clinical trial and research data
Recap: Marinus Pharmaceuticals Q3 Earnings
Marinus Pharmaceuticals (NASDAQ:MRNS) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Marinus Pharmaceuticals Q3 EPS $(0.53) Beats $(0.73) Estimate, Sales $10.11M Up From $171.00K YoY
Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.73) by 27.4 percent. This is a 3.92 percent decrease over losses of $(0.51) per share
Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
European Medicines Agency Grants Marinus Pharmaceuticals Accelerated Assessment of Ganaxolone for Treatment of CDKL5 Deficiency Disorder
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the Committee for Medicinal Products for
